These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 8396627)
1. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets. Vickers JD J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627 [TBL] [Abstract][Full Text] [Related]
2. The decrease in phosphatidylinositol 4,5-bisphosphate in ADP-stimulated washed rabbit platelets is not primarily due to phospholipase C activation. Vickers JD; Kinlough-Rathbone RL; Mustard JF Biochem J; 1986 Jul; 237(2):327-32. PubMed ID: 3026316 [TBL] [Abstract][Full Text] [Related]
3. U73122, an aminosteroid phospholipase C inhibitor, is a potent inhibitor of cardiac phospholipase D by a PIP2-dependent mechanism. Burgdorf C; Schäfer U; Richardt G; Kurz T J Cardiovasc Pharmacol; 2010 Jun; 55(6):555-9. PubMed ID: 20179606 [TBL] [Abstract][Full Text] [Related]
4. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation. Lockhart LK; McNicol A J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645 [TBL] [Abstract][Full Text] [Related]
5. Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets. Ryningen A; Olav Jensen B; Holmsen H Biochim Biophys Acta; 1998 Nov; 1394(2-3):235-48. PubMed ID: 9795233 [TBL] [Abstract][Full Text] [Related]
6. Activation of phospholipase C associated with isolated rabbit platelet membranes by guanosine 5'-[gamma-thio]triphosphate and by thrombin in the presence of GTP. Hrbolich JK; Culty M; Haslam RJ Biochem J; 1987 Apr; 243(2):457-65. PubMed ID: 2820381 [TBL] [Abstract][Full Text] [Related]
7. The phosphoinositide-specific phospholipase C inhibitor U73122 (1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione) spontaneously forms conjugates with common components of cell culture medium. Wilsher NE; Court WJ; Ruddle R; Newbatt YM; Aherne W; Sheldrake PW; Jones NP; Katan M; Eccles SA; Raynaud FI Drug Metab Dispos; 2007 Jul; 35(7):1017-22. PubMed ID: 17403917 [TBL] [Abstract][Full Text] [Related]
8. Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets. Pandey SC; Davis JM; Schwertz DW; Pandey GN J Pharmacol Exp Ther; 1991 Mar; 256(3):1010-8. PubMed ID: 1672374 [TBL] [Abstract][Full Text] [Related]
9. Effect of chlorpromazine on inositol-lipid signalling system in human thrombocytes. Strunecká A; Rípová D; Folk P Physiol Bohemoslov; 1987; 36(6):495-501. PubMed ID: 2830631 [TBL] [Abstract][Full Text] [Related]
10. Bradykinin- and thrombin-induced increases in endothelial permeability occur independently of phospholipase C but require protein kinase C activation. Aschner JL; Lum H; Fletcher PW; Malik AB J Cell Physiol; 1997 Dec; 173(3):387-96. PubMed ID: 9369952 [TBL] [Abstract][Full Text] [Related]
11. In vivo activity of a phospholipase C inhibitor, 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions. Hou C; Kirchner T; Singer M; Matheis M; Argentieri D; Cavender D J Pharmacol Exp Ther; 2004 May; 309(2):697-704. PubMed ID: 14730005 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. Bleasdale JE; Thakur NR; Gremban RS; Bundy GL; Fitzpatrick FA; Smith RJ; Bunting S J Pharmacol Exp Ther; 1990 Nov; 255(2):756-68. PubMed ID: 2147038 [TBL] [Abstract][Full Text] [Related]
13. 1-[6-[[(17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122) selectively inhibits Kir3 and BK channels in a phospholipase C-independent fashion. Klose A; Huth T; Alzheimer C Mol Pharmacol; 2008 Nov; 74(5):1203-14. PubMed ID: 18682550 [TBL] [Abstract][Full Text] [Related]
14. Capacitative Ca2+ entry in human platelets is resistant to nitric oxide. Okamoto Y; Ninomiya H; Miwa S; Masaki T Biochem Biophys Res Commun; 1995 Jul; 212(1):90-6. PubMed ID: 7612023 [TBL] [Abstract][Full Text] [Related]
15. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism. Nunez D; Randon J; Gandhi C; Siafaka-Kapadai A; Olson MS; Hanahan DJ J Biol Chem; 1990 Oct; 265(30):18330-8. PubMed ID: 2170407 [TBL] [Abstract][Full Text] [Related]
16. Ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) and the tyrphostin ST271 inhibit phospholipase C in human platelets by preventing Ca2+ entry. Watson SP; Poole A; Asselin J Mol Pharmacol; 1995 Apr; 47(4):823-30. PubMed ID: 7723744 [TBL] [Abstract][Full Text] [Related]
18. The role of the phosphatidylinositol turnover in 12-hydroxyeicosatetraenoic acid generation from human platelets by Escherichia coli alpha-haemolysin, thrombin and fluoride. König B; König W Immunology; 1993 Dec; 80(4):633-9. PubMed ID: 8307614 [TBL] [Abstract][Full Text] [Related]
19. Identification of polyphosphoinositide-specific phospholipase C and its resolution from phosphoinositide-specific phospholipase C from human platelet extract. Manne V Oncogene; 1987; 2(1):49-54. PubMed ID: 2830583 [TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated signalling pathways acting through hydrolysis of membrane phospholipids in cardiomyocytes. Lamers JM; De Jonge HW; Panagia V; Van Heugten HA Cardioscience; 1993 Sep; 4(3):121-31. PubMed ID: 8400019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]